AAAAAA

   
Results: 1-21 |
Results: 21
SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC WOLFF M GORSE GJ GRAHAM BS COREY L CLEMENTSMANN ML VERANIKETTER N ERB S SMITH CM BELSHE RB WAGNER LJ MCELRATH MJ SCHWARTZ DH FAST P CHARRON K REYNOLDS MJ ZIMMERMAN E JONES K HARRIS M FREY SE KENNEDY DJ ISRAEL H BERRY C READ B SPITZ T PACATTE T DOLIN R REICHMAN RC LAMBERT J DEMETER L ROBERTS NJ PUGLIESE M BERGER D BURKE J SCOTT T BLACKSTONE E WRIGHT PF BRAEUNER M RYBCZYK GK CRUMBO K BATTLE W CORNELL R OWENS D JENNINGS M HARBISON MA HENSMAN BJ BARR P STABLEIN DM VOSS T PALLAS S LOMAX N KOFF W LAWRENCE D JOHNSTON M SAVARESE B WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177
MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE CLINICAL-TRIALS IN TRANSPLANTATION PILOT-STUDY
Authors: DELMONICO FL COSIMI AB COLVIN R FARRELL ML THISTLETHWAITE R SPARGO B OLAUGHLIN R MATAS AJ BURKE B MCHUGH L LINDBLAD AS STABLEIN DM CARTERCAMPBELL S SALOMON DR QUINN S HAVERTY T KNOWLES R KALE R
Citation: Fl. Delmonico et al., MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE CLINICAL-TRIALS IN TRANSPLANTATION PILOT-STUDY, Transplantation, 63(9), 1997, pp. 1243-1251
MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE CLINICAL-TRIAL IN A TRANSPLANTATION PILOT-STUDY
Authors: DELMONICO FL COSIMI AB COLVIN R FARRELL ML THISTLETHWAITE R SPARGO B OLAUGHLIN R MATAS AJ BURKE B MCHUGH L LINDBLAD AS STABLEIN DM CARTERCAMPBELL S SALOMON DR QUINN S HAVERTY T KNOWLES R KALE R
Citation: Fl. Delmonico et al., MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE CLINICAL-TRIAL IN A TRANSPLANTATION PILOT-STUDY, Transplantation, 63(8), 1997, pp. 1087-1095
SAFETY AND IMMUNOGENICITY OF ENV-2-3, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE, IN COMBINATION WITH A NOVEL ADJUVANT, MTP-PEMF59/
Authors: KEEFER MC GRAHAM BS MCELRATH MJ MATTHEWS TJ STABLEIN DM COREY L WRIGHT PF LAWRENCE D FAST PE WEINHOLD K HSIEH RH CHERNOFF D DEKKER C DOLIN R
Citation: Mc. Keefer et al., SAFETY AND IMMUNOGENICITY OF ENV-2-3, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE, IN COMBINATION WITH A NOVEL ADJUVANT, MTP-PEMF59/, AIDS research and human retroviruses, 12(8), 1996, pp. 683-693
RESULTS OF CONTROLLED-STUDY OF COMBINATION THERAPY WITH AZATHIOPRINE AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS REVISITED - REPLY
Authors: WILLKENS RF MARKS C SHARP JT STABLEIN DM WORTMANN R
Citation: Rf. Willkens et al., RESULTS OF CONTROLLED-STUDY OF COMBINATION THERAPY WITH AZATHIOPRINE AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS REVISITED - REPLY, Arthritis and rheumatism, 39(8), 1996, pp. 1436-1437
SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL
Authors: GRAHAM BS KEEFER MC MCELRATH MJ GORSE GJ SCHWARTZ DH WEINHOLD K MATTHEWS TJ ESTERLITZ JR SINANGIL F FAST PE WRIGHT PF DOLIN R COREY L BELSHE RB CLEMENTS ML BOLOGNESI DP STABLEIN DM CHERNOFF D DULIEGE AM WALKER CM
Citation: Bs. Graham et al., SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL, Annals of internal medicine, 125(4), 1996, pp. 270
DO CHILDREN EXHIBIT CATCH-UP GROWTH POST TRANSPLANT - NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY SPECIAL STUDY
Authors: FINE RN STABLEIN DM TEJANI A
Citation: Rn. Fine et al., DO CHILDREN EXHIBIT CATCH-UP GROWTH POST TRANSPLANT - NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY SPECIAL STUDY, Pediatric nephrology, 9, 1995, pp. 66-68
RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS - A REPORT OFTHE NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY
Authors: KASHTAN CE MCENERY PT TEJANI A STABLEIN DM
Citation: Ce. Kashtan et al., RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS - A REPORT OFTHE NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY, Pediatric nephrology, 9(6), 1995, pp. 679-684
HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
Authors: GORSE GJ ROGERS JH PERRY JE NEWMAN FK FREY SE PATEL GB BELSHE RB SCHWARTZ DH CLEMENTS ML KEEFER M DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT PF STABLEIN DM MATTHEWS TJ BOLOGNESI D MESTECKY J WALKER MC FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA, Vaccine, 13(2), 1995, pp. 209-214
MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE PILOT-STUDY (REPORT-1)
Authors: DELMONICO FL COLVIN R FARRELL M THISTLETHWAITE R SPARGO B OLAUGHLIN R MATAS AJ BURKE B MCHUGH L LINDBLAD AS STABLEIN DM CARTERCAMPBELL S SALOMON D LAUBER S HILLER M RAYGOR K HAVERTY T KNOWLES R KALE R
Citation: Fl. Delmonico et al., MURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL-ALLOGRAFT RECIPIENTS - A COOPERATIVE PILOT-STUDY (REPORT-1), Transplantation proceedings, 27(1), 1995, pp. 863-863
STUDIES OF HIGH-DOSES OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GLYCOPROTEIN-160 CANDIDATE VACCINE IN HIV TYPE-1-SERONEGATIVE HUMANS
Authors: KEEFER MC GRAHAM BS BELSHE RB SCHWARTZ D COREY L BOLOGNESI DP STABLEIN DM MONTEFIORI DC MCELRATH MJ CLEMENTS ML GORSE GJ WRIGHT PF MATTHEWS TJ SMITH GE LAWRENCE D DOLIN R
Citation: Mc. Keefer et al., STUDIES OF HIGH-DOSES OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GLYCOPROTEIN-160 CANDIDATE VACCINE IN HIV TYPE-1-SERONEGATIVE HUMANS, AIDS research and human retroviruses, 10(12), 1994, pp. 1713-1723
NEUTRALIZING ANTIBODIES TO HIV-1 IN SERONEGATIVE VOLUNTEERS IMMUNIZEDWITH RECOMBINANT GP120 FROM THE MN STRAIN OF HIV-1
Authors: BELSHE RB GRAHAM BS KEEFER MC GORSE GJ WRIGHT P DOLIN R MATTHEWS T WEINHOLD K BOLOGNESI DP SPOSTO R STABLEIN DM TWADDELL T BERMAN PW GREGORY T IZU AE WALKER MC FAST P
Citation: Rb. Belshe et al., NEUTRALIZING ANTIBODIES TO HIV-1 IN SERONEGATIVE VOLUNTEERS IMMUNIZEDWITH RECOMBINANT GP120 FROM THE MN STRAIN OF HIV-1, JAMA, the journal of the American Medical Association, 272(6), 1994, pp. 475-480
RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS IN NORTH-AMERICAN CHILDREN - A REPORT OF NAPRTCS
Authors: MCENERY PT KASHTAN CE STABLEIN DM TEJANI A
Citation: Pt. Mcenery et al., RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS IN NORTH-AMERICAN CHILDREN - A REPORT OF NAPRTCS, Pediatric research, 35(4), 1994, pp. 10000369-10000369
LONG-TERM EFFICACY AND SAFETY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS
Authors: BURKE JF PIRSCH JD RAMOS EL SALOMON DR STABLEIN DM VANBUREN DH WEST JC
Citation: Jf. Burke et al., LONG-TERM EFFICACY AND SAFETY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS, The New England journal of medicine, 331(6), 1994, pp. 358-363
DETERMINANTS OF ANTIBODY-RESPONSE AFTER RECOMBINANT GP160 BOOSTING INVACCINIA-NAIVE VOLUNTEERS PRIMED WITH GP160-RECOMBINANT VACCINIA VIRUS
Authors: GRAHAM BS GORSE GJ SCHWARTZ DH KEEFER MC MCELRATH MJ MATTHEWS TJ WRIGHT PF BELSHE RB CLEMENTS ML DOLIN R COREY L BOLOGNESI DP STABLEIN DM ESTERLITZ JR HU SL SMITH GE
Citation: Bs. Graham et al., DETERMINANTS OF ANTIBODY-RESPONSE AFTER RECOMBINANT GP160 BOOSTING INVACCINIA-NAIVE VOLUNTEERS PRIMED WITH GP160-RECOMBINANT VACCINIA VIRUS, The Journal of infectious diseases, 170(4), 1994, pp. 782-786
HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
Authors: GORSE GJ SCHWARTZ DH GRAHAM BS MATTHEWS TJ STABLEIN DM FREY SE BELSHE RB CLEMENTS ML WRIGHT PF EIBL M FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES, Clinical and experimental immunology, 98(2), 1994, pp. 178-184
PREOPERATIVE AND POSTOPERATIVE COMBINATION CHEMOTHERAPY FOR POTENTIALLY RESECTABLE GASTRIC-CARCINOMA
Authors: AJANI JA MAYER RJ OTA DM STEELE GD EVANS D ROH M SUGARBAKER DJ DUMAS P GRAY C VENA DA STABLEIN DM
Citation: Ja. Ajani et al., PREOPERATIVE AND POSTOPERATIVE COMBINATION CHEMOTHERAPY FOR POTENTIALLY RESECTABLE GASTRIC-CARCINOMA, Journal of the National Cancer Institute, 85(22), 1993, pp. 1839-1844
5-YEAR PATIENT AND GRAFT-SURVIVAL IN NORTH-AMERICAN CHILDREN - A REPORT OF THE RICAN-PEDIATRIC-RENAL-TRANSPLANT-COOPERATIVE-STUDY
Authors: STABLEIN DM TEJANI A
Citation: Dm. Stablein et A. Tejani, 5-YEAR PATIENT AND GRAFT-SURVIVAL IN NORTH-AMERICAN CHILDREN - A REPORT OF THE RICAN-PEDIATRIC-RENAL-TRANSPLANT-COOPERATIVE-STUDY, Kidney international, 44, 1993, pp. 190000016-190000021
MAINTENANCE DIALYSIS IN NORTH-AMERICAN CHILDREN AND ADOLESCENTS - A PRELIMINARY-REPORT
Authors: ALEXANDER SR SULLIVAN EK HARMON WE STABLEIN DM TEJANI A
Citation: Sr. Alexander et al., MAINTENANCE DIALYSIS IN NORTH-AMERICAN CHILDREN AND ADOLESCENTS - A PRELIMINARY-REPORT, Kidney international, 44, 1993, pp. 190000104-190000109
SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION
Authors: BELSHE RB CLEMENTS ML DOLIN R GRAHAM BS MCELRATH J GORSE GJ SCHWARTZ D KEEFER MC WRIGHT P COREY L BOLOGNESI DP MATTHEWS TJ STABLEIN DM OBRIEN FS EIBL M DORNER F KOFF W
Citation: Rb. Belshe et al., SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1387-1395
COMBINATION THERAPY OF RA WITH METHOTREXATE AND AZATHIOPRINE - 48 WEEK RESULTS
Authors: WILLKENS RF UROWITZ ME SHARP JE STABLEIN DM
Citation: Rf. Willkens et al., COMBINATION THERAPY OF RA WITH METHOTREXATE AND AZATHIOPRINE - 48 WEEK RESULTS, Arthritis and rheumatism, 36(9), 1993, pp. 190000053-190000053
Risultati: 1-21 |